Amy Gill

Amy Gill is a Disease Level Partner at Roche, where they have worked for over seven years, specializing in Multiple Sclerosis, Haematology, Rheumatology, and Oncology. With more than 15 years of experience in the pharmaceutical industry, they have a proven track record in launching high-value products in challenging markets. Prior to Roche, Amy held positions at Bayer, Abraxis BioScience/Celgene, Sanofi, and Yamanouchi Pharmaceutical Co, where they developed key business strategies and facilitated various product launches. Their expertise includes strong KOL management and successful funding facilitation across multiple therapeutic areas.